1,1,1,-TRIFLUORO-4-PHENYL-4-METHYL-2-(1H-PYRROLO

Compounds of Formula (IA), IB), IC), and (ID) wherein R1, R2, R3, R4, R5, and R6 are as respectively defined herein for Formula (IA), (IB), (IC), and (ID), or a tautomer, prodrug, solvate, or salt thereof; pharmaceutical compositions containing such compounds, and methods of modulating the glucocort...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	ZINDELL RENEE, LIU PINGRONG, BETAGERI RAJASHKHAR, RIETHER DORIS, THOMSON DAVID, HAMMACH ABDELHAKIM, TAKAHASHI HIDENORI, PATEL USHA R, HARCKEN CHRISTIAN H.J.J, WANG JI, RAZAVI HOSSEIN, LEE THOMAS WAI-HO, KUZMICH DANIEL, PROUDFOOT JOHN ROBERT, BEKKALI YOUNES, KIRRANE THOMAS MARTIN, EMMANUEL MICHEL J
Format:	Patent
Sprache:	eng ; srp
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!